We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
High serum perfluorooctanoic acid (PFOA) concentrations and interstitial lung disease in former and current workers in a fluorochemical company
Summary
This study examines health outcomes in populations with elevated serum concentrations of PFOA, a persistent per- and polyfluoroalkyl substance (PFAS). Findings link high PFOA exposure to a range of adverse health effects, adding to the evidence base for PFAS regulation.
In 2002, Daikin Industries' Yodogawa Plant (DIYP) in Settsu City in Japan had contaminated drinking water in Hanshin area with (PFOA), leading to the complete cessation of PFOA production in 2012. In 2023, local residents conducted a voluntary Blood Monitoring Campaign with 1,182 general residents. Blood monitoring was also conducted for former or current workers from DIYP and farming residents in Settsu City. Serum PFOA concentrations determined by gas chromatography with mass spectrometry [number: ng/ml: median (25th-75th percentile)] were as follows: former and current workers [N=7: 192.6 (23.3-596.6)] >farming residents [N=5: 70.2 (50.4-98.8)] >general residents [N=1182: 5.0 (3.3-7.0)] with significant differences (Kruskal-Wallis test, p<0.001). In a study, 4 out of 5 farming residents showed a serum PFOA decline (half-life: 2.2 yr, 95% CI: 1.4-4.6) after stopping local agricultural product consumption. However, 3 former workers exhibited no decrease over 0.8-0.9 yr. An investigation found that 5 of the 7 subjects were likely exposed to dust from the polymerization of tetrafluoroethylene or handling its particulate matters, with 3 showing Interstitial Lung Disease (ILD) signs. This suggests PFOA-laden dust may delay excretion and contribute to ILD, though the mechanistic link remains unclear, requiring further research.